Intelligent Hair Growth Stimulation Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates dutasteride-based topical compositions with cutting-edge technologies like AI, IoT, blockchain, and nanomaterials to create a new generation of personalized hair growth stimulation systems.
Background and Problem Solved
The original patent disclosed topical compositions of dutasteride for preventing hair loss and stimulating hair growth. However, the original patent's limitations include lack of personalized treatment, inefficient application, and authenticity concerns. The new inventive concept addresses these limitations by incorporating advanced technologies to provide a more effective, efficient, and secure hair growth stimulation system.
Detailed Description of the Inventive Concept
The new inventive concept encompasses five distinct embodiments. The first embodiment combines a dutasteride-based topical composition with an AI-powered monitoring device, which tracks hair growth and provides personalized recommendations for optimizing treatment. The second embodiment integrates the topical composition with IoT-enabled sensors, allowing for real-time monitoring and adjustment of the composition's application based on environmental factors. The third embodiment utilizes a blockchain-based platform to ensure the authenticity and secure transactions of the topical compositions. The fourth embodiment incorporates a wearable device with nanomaterials to enhance transdermal delivery of the composition. The fifth embodiment employs machine learning algorithms to analyze individual hair growth patterns and generate customized topical compositions containing dutasteride.
Novelty and Inventive Step
The new inventive concept's novelty lies in the synergistic integration of dutasteride-based topical compositions with advanced technologies, providing a holistic approach to hair growth stimulation. The inventive step is the recognition of the benefits of combining these technologies to create a more effective, efficient, and secure system.
Alternative Embodiments and Variations
Alternative embodiments may include the use of other 5α-reductase inhibitors, different AI-powered monitoring devices, or various IoT-enabled sensors. Additionally, the blockchain-based platform could be adapted for use with other cosmetic products or pharmaceuticals. The wearable device could be modified to incorporate other nanomaterials or transdermal delivery mechanisms.
Potential Commercial Applications and Market
The intelligent hair growth stimulation systems have significant commercial potential in the cosmetic and pharmaceutical industries, targeting the growing demand for personalized hair care solutions. The market for hair loss treatments is expected to continue growing, driven by increasing consumer awareness and demand for effective solutions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulations, topical drug delivery systems, and cosmetic/medical hair loss treatments, with expertise in 5α-reductase inhibitor compositions and advanced drug delivery technologies
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or biotechnology, possessing knowledge of drug formulation, transdermal delivery mechanisms, and emerging technologies in personalized medicine
Obviousness Rationale
A PHOSITA would recognize that integrating advanced monitoring and personalization technologies with existing dutasteride-based hair loss compositions represents a predictable extension of known pharmaceutical and digital health approaches. The core dutasteride composition remains substantially unchanged, while technological augmentations provide enhanced treatment monitoring and customization. These technological integrations reflect standard industry practices of combining pharmaceutical formulations with digital health innovations to improve patient outcomes and treatment efficacy.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,556 |
|---|---|
| Title | Topical compositions of dutasteride |
| Assignee(s) | SHILPA MEDICARE LIMITED |